4DMedical Limited (ASX:4DX)
1.430
-0.040 (-2.72%)
Nov 14, 2025, 10:09 AM AEST
4DMedical Revenue
In the fiscal year ending June 30, 2025, 4DMedical had annual revenue of 5.85M AUD with 55.91% growth. 4DMedical had revenue of 2.96M in the half year ending June 30, 2025, with 1,171.16% growth.
Revenue
5.85M
Revenue Growth
+55.91%
P/S Ratio
128.39
Revenue / Employee
47.20K
Employees
124
Market Cap
751.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.85M | 2.10M | 55.91% |
| Jun 30, 2024 | 3.75M | 3.04M | 422.45% |
| Jun 30, 2023 | 718.58K | -335.72K | -31.84% |
| Jun 30, 2022 | 1.05M | 837.32K | 385.90% |
| Jun 30, 2021 | 216.98K | -1.02M | -82.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |